Funding news
bythen logo

Bythen Secures $3 Million in Seed Funding for Innovative AI Avatar Technology

Recently funded · $3.0M SeedTechnology, Information and Internet

Get the full bythen company profile

Access contacts, investors, buying signals & more

Open in Dashboard

We are thrilled to announce that bythen has successfully raised $3 million in its latest funding round, aimed at advancing our innovative AI product protocol. This significant investment will empower us to continue our mission of revolutionizing how humans engage with technology through the development of AI-powered, 3D avatar agents that boast autonomous capabilities. At bythen, we believe in the transformative power of artificial intelligence to make our lives easier and more productive. Our cutting-edge protocol facilitates the creation of interactive avatars that can assist users in various tasks, from personal organization to complex project management, ultimately enabling them to achieve more with less effort. This funding will not only bolster our research and development efforts but also enhance the deployment of our avatars in diverse industries ranging from education to entertainment, providing tailored solutions that meet the specific needs of our users. We are excited to leverage this investment to refine our technology and expand our team of talented professionals, ensuring that we remain at the forefront of AI innovation. The journey ahead is promising, and we invite you to join us as we explore the limitless potential of AI-powered digital agents, transforming everyday experiences and unlocking new avenues for creativity and efficiency. Thank you to our investors for believing in our vision; together, we will forge a future where humans and AI seamlessly collaborate to elevate productivity and enrich lives.

Other recently funded companies

View all

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Edify logo

Edify

United States

$3.0M
2
Riverlution logo

Riverlution

United Kingdom

$40.4K
3
Goldenrod Therapeutics logo

Goldenrod Therapeutics

United States

$6.5M
4
HAGA.BIO logo

HAGA.BIO

Sweden

$2.3M
5
Hexigone Inhibitors logo

Hexigone Inhibitors

United Kingdom

$1.2M